These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22693640)

  • 1. Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.
    Chegou NN; Essone PN; Loxton AG; Stanley K; Black GF; van der Spuy GD; van Helden PD; Franken KL; Parida SK; Klein MR; Kaufmann SH; Ottenhoff TH; Walzl G
    PLoS One; 2012; 7(6):e38501. PubMed ID: 22693640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.
    Essone PN; Chegou NN; Loxton AG; Stanley K; Kriel M; van der Spuy G; Franken KL; Ottenhoff TH; Walzl G
    PLoS One; 2014; 9(7):e102584. PubMed ID: 25025278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.
    Chegou NN; Black GF; Loxton AG; Stanley K; Essone PN; Klein MR; Parida SK; Kaufmann SH; Doherty TM; Friggen AH; Franken KL; Ottenhoff TH; Walzl G
    BMC Infect Dis; 2012 Jan; 12():10. PubMed ID: 22260319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.
    Black GF; Thiel BA; Ota MO; Parida SK; Adegbola R; Boom WH; Dockrell HM; Franken KL; Friggen AH; Hill PC; Klein MR; Lalor MK; Mayanja H; Schoolnik G; Stanley K; Weldingh K; Kaufmann SH; Walzl G; Ottenhoff TH;
    Clin Vaccine Immunol; 2009 Aug; 16(8):1203-12. PubMed ID: 19553548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
    Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
    Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.
    Kassa D; Ran L; Geberemeskel W; Tebeje M; Alemu A; Selase A; Tegbaru B; Franken KL; Friggen AH; van Meijgaarden KE; Ottenhoff TH; Wolday D; Messele T; van Baarle D
    Clin Vaccine Immunol; 2012 Dec; 19(12):1907-15. PubMed ID: 23015647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
    Sutherland JS; de Jong BC; Jeffries DJ; Adetifa IM; Ota MO
    PLoS One; 2010 Aug; 5(8):e12365. PubMed ID: 20811496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Whole Blood Chemiluminescent Immunoassay of Interferon-gamma Inducible Protein 10 (IP-10) for Diagnosis of Tuberculosis Patients.
    Wang Y; Yang Y; Li H; Liang Y; Liu J; Yu T; Wu X
    Clin Lab; 2016; 62(1-2):165-72. PubMed ID: 27012046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.
    Leem AY; Song JH; Lee EH; Lee H; Sim B; Kim SY; Chung KS; Kim EY; Jung JY; Park MS; Kim YS; Chang J; Kang YA
    Sci Rep; 2018 Jan; 8(1):1159. PubMed ID: 29348638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of
    Kimuda SG; Nalwoga A; Levin J; Franken KL; Ottenhoff TH; Elliott AM; Cose S; Andia-Biraro I
    J Immunol Res; 2017; 2017():1593143. PubMed ID: 28255560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
    Hasan Z; Jamil B; Ashraf M; Islam M; Dojki M; Irfan M; Hussain R
    Clin Vaccine Immunol; 2009 Jul; 16(7):991-8. PubMed ID: 19439524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoarabinomannan-specific TNF-α and IFN-γ as markers of protective immunity against tuberculosis: a cohort study in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Bjune G; Abebe F
    APMIS; 2015 Oct; 123(10):851-7. PubMed ID: 26200933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.